ILF3 and lung carcinoma: Three differentially expressed lncRNAs listed in the CDEGs, namely, ILF3-AS1 (Chen et al., 2021), JPX (Li et al., 2021), and RPPH1 (Wu et al., 2020), have already been reported to be involved in the progression of lung cancer by affecting cell proliferation and migration.